Preclinical data and design of a phase I clinical trial of neoantigen-reactive TILs for advanced epithelial or ICB-resistant solid cancers. - Palomero J; Galvao V; Creus I; Lostes J; Aylagas M; Marín-Bayo A; Rotxés M; Sanz M; Lozano-Rabella M; Garcia-Garijo A; Yuste-Estevanez A; Grases D; et al. (Immuno-oncology technology, 2024)